-
101
Letter to the editor: effects of radiotherapy exposure on fruquintinib plus sintilimab treatment in refractory microsatellite stable metastatic colorectal cancer—a prospective obse...
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
102
Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy
Published 2016-09-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
103
Exosomal circPOLQ promotes macrophage M2 polarization via activating IL-10/STAT3 axis in a colorectal cancer model
Published 2024-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
104
PD-L1/TLR7 dual-targeting nanobody-drug conjugate mediates potent tumor regression via elevating tumor immunogenicity in a host-expressed PD-L1 bias-dependent way
Published 2022-10-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
105
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types
Published 2024-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
106
Glut3 overexpression improves environmental glucose uptake and antitumor efficacy of CAR-T cells in solid tumors
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
107
Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases
Published 2023-08-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
108
CD47/SIRPα axis: bridging innate and adaptive immunity
Published 2022-07-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
109
High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC
Published 2024-12-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
110
Diabetes insipidus and Guillain-Barré-like syndrome following CAR-T cell therapy: a case report
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
111
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy
Published 2023-08-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
112
Association of age, race, and ethnicity with access, response, and toxicities from CAR-T therapy in children and adults with B-cell malignancies: a review
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
113
Art of TIL immunotherapy: SITC’s perspective on demystifying a complex treatment
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
114
Teaching an old dog new tricks: re-engineering IL-2 for immuno-oncology applications
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
115
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
116
Generation of novel oncolytic vaccinia virus with improved intravenous efficacy through protection against complement-mediated lysis and evasion of neutralization by vaccinia virus...
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
117
Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?
Published 2024-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
118
Spontaneous, naturally occurring cancers in non-human primates as a translational model for cancer immunotherapy
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
119
Intratumoral pan-ErbB targeted CAR-T for head and neck squamous cell carcinoma: interim analysis of the T4 immunotherapy study
Published 2023-06-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
120
Human blood cell transcriptomics unveils dynamic systemic immune modulation along colorectal cancer progression
Published 2024-11-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article